All lobbying filings

CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for OCTAPHARMA USA, INC. · Pharmaceuticals

Filing Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 16, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Trade (domestic/foreign)

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Medical/Disease Research/Clinical Labs

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Manufacturing

Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.